Welcome to Medications.com

Hyperion Therapeutics, Inc. Announces Senior Management Team and ... - Genetic Engineering News (press release)

... (Dynacin(R)), respiratory (Azmacort(R), Intal(R), and Orapred(R)) and rare metabolic disorders (AMMONUL and BUPHENYL(R) (sodium phenylbutyrate)). ...

http://www.genengnews.com/news/bn... | Posted: Thu Oct 04 05:29:03 -0400 2007




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea